CAM
Cormorant Asset Management’s Y-mAbs Therapeutics YMAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-425,000
| Closed | -$3.33M | – | 49 |
|
|
2024
Q4 | $3.33M | Sell |
425,000
-1,025,000
| -71% | -$8.03M | 0.18% | 41 |
|
|
2024
Q3 | $19.1M | Hold |
1,450,000
| – | – | 1.01% | 31 |
|
|
2024
Q2 | $17.5M | Buy |
+1,450,000
| New | +$17.5M | 1.01% | 29 |
|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$732K | – | 82 |
|
|
2022
Q4 | $732K | Hold |
150,000
| – | – | 0.05% | 68 |
|
|
2022
Q3 | $2.16M | Hold |
150,000
| – | – | 0.15% | 59 |
|
|
2022
Q2 | $2.27M | Hold |
150,000
| – | – | 0.17% | 60 |
|
|
2022
Q1 | $1.78M | Sell |
150,000
-150,000
| -50% | -$1.78M | 0.14% | 68 |
|
|
2021
Q4 | $4.86M | Sell |
300,000
-200,000
| -40% | -$3.24M | 0.29% | 55 |
|
|
2021
Q3 | $14.3M | Sell |
500,000
-300,000
| -38% | -$8.56M | 0.58% | 44 |
|
|
2021
Q2 | $27M | Sell |
800,000
-430,000
| -35% | -$14.5M | 0.92% | 27 |
|
|
2021
Q1 | $37.2M | Sell |
1,230,000
-431,647
| -26% | -$13.1M | 0.83% | 28 |
|
|
2020
Q4 | $82.3M | Buy |
1,661,647
+263,947
| +19% | +$13.1M | 1.96% | 9 |
|
|
2020
Q3 | $53.7M | Sell |
1,397,700
-176,983
| -11% | -$6.79M | 2.06% | 12 |
|
|
2020
Q2 | $68M | Sell |
1,574,683
-157,517
| -9% | -$6.8M | 2.6% | 7 |
|
|
2020
Q1 | $45.2M | Buy |
1,732,200
+129,824
| +8% | +$3.39M | 2.1% | 13 |
|
|
2019
Q4 | $50.1M | Buy |
1,602,376
+718,576
| +81% | +$22.5M | 2% | 16 |
|
|
2019
Q3 | $23M | Sell |
883,800
-116,200
| -12% | -$3.03M | 1.4% | 21 |
|
|
2019
Q2 | $22.9M | Buy |
1,000,000
+284,518
| +40% | +$6.51M | 1.31% | 22 |
|
|
2019
Q1 | $18.8M | Buy |
715,482
+520,714
| +267% | +$13.6M | 1.27% | 27 |
|
|
2018
Q4 | $3.96M | Sell |
194,768
-5,232
| -3% | -$106K | 0.32% | 51 |
|
|
2018
Q3 | $5.31M | Buy |
+200,000
| New | +$5.31M | 0.35% | 45 |
|